World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
18355
World Ranking
18896
National Ranking
758

Mario Mercuri publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mario Mercuri sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 304 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mario Mercuri D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mario Mercuri sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mario Mercuri was affiliated with the University of Bologna in Italy and contributed extensively to the field of Engineering, with particular focus on Biomedical Engineering, Surgery, Electrical and Electronic Engineering, Cardiology and Cardiovascular Medicine, and Aerospace Engineering.

Their research output concentrated on several key topics including:

  • Non-Invasive Vital Sign Monitoring
  • Healthcare Technology and Patient Monitoring
  • Indoor and Outdoor Localization Technologies
  • ECG Monitoring and Analysis
  • Microwave Imaging and Scattering Analysis
  • Radar Systems and Signal Processing
  • Context-Aware Activity Recognition Systems

The frequent publication venues for their work included:

  • IEEE Microwave Magazine
  • IEEE Transactions on Biomedical Engineering
  • Scientific Reports
  • IEEE Journal of Electromagnetics RF and Microwaves in Medicine and Biology
  • Sensors

Coauthors who collaborated most often with them were:

  • Ping Jack Soh
  • Dominique Schreurs
  • Pouya Mehrjouseresht
  • Tomislav Marković
  • Xuezhi Zheng

Their recent papers demonstrated a focus on radar and localization technologies related to health monitoring. Papers included:

  • "2-D Localization, Angular Separation and Vital Signs Monitoring Using a SISO FMCW Radar for Smart Long-Term Health Monitoring Environments," published in 2021 in IEEE Internet of Things Journal
  • "Enabling Robust Radar-Based Localization and Vital Signs Monitoring in Multipath Propagation Environments," published in 2021 in IEEE Transactions on Biomedical Engineering
  • "A Survey on Vital Signs Detection Using Radar Techniques and Processing With FPGA Implementation," published in 2021 in IEEE Circuits and Systems Magazine
  • "Automatic radar-based 2-D localization exploiting vital signs signatures," published in 2022 in Scientific Reports
  • "Biomedical Radar System for Real-Time Contactless Fall Detection and Indoor Localization," published in 2023 in IEEE Journal of Electromagnetics RF and Microwaves in Medicine and Biology

Best Publications

  • Primary bone osteosarcoma in the pediatric age: State of the art

    Alessandra Longhi;Costantino Errani;Massimiliano De Paolis;Mario Mercuri

  • Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.

    Gaetano Bacci;Alessandra Longhi;Michela Versari;Mario Mercuri

  • Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review

    Eric R. Henderson;John S. Groundland;Elisa Pala;Jeremy A. Dennis

  • Platelet-derived growth factors enhance proliferation of human stromal stem cells.

    Enrico Lucarelli;Amira Beccheroni;Davide Donati;Luca Sangiorgi

  • Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

    Stefano Ferrari;Sigbjorn Smeland;Mario Mercuri;Franco Bertoni

  • Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

    Gaetano Bacci;Piero Picci;Stefano Ferrari;Pietro Ruggieri M.D.

  • Giant cell tumor of the extremity: A review of 349 cases from a single institution.

    Costantino Errani;Pietro Ruggieri;Marco Antonio Nogales Asenzio;Angelo Toscano

  • A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

    G Grignani;Emanuela Palmerini;P. Dileo;S. D. Asaftei

  • Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

    Stefano Ferrari;Antonio Briccoli;Mario Mercuri;Franco Bertoni

  • Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin

    G. Bacci;P. Picci;P. Ruggieri;M. Mercuri

  • Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.

    P Picci;T Böhling;G Bacci;S Ferrari

  • Massive bone allograft reconstruction in high-grade osteosarcoma.

    Davide Donati;Michele Di Liddo;Marcello Zavatta;Marco Manfrini

  • Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.

    P Picci;B T Rougraff;G Bacci;J R Neff

  • Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.

    Silvia Stacchiotti;Paolo Giovanni Casali;Salvatore Lo Vullo;Luigi Mariani

  • Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy.

    G. Bacci;S. Ferrari;S. Lari;M. Mercuri

  • Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute

    S. Ferrari;F. Bertoni;M. Mercuri;P. Picci

  • Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas : a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group

    Alessandro Gronchi;Sergio Frustaci;Mario Mercuri;Javier Martin

  • Italian cooperative study for the treatment of children and young adults with localized Ewing sarcoma of bone a preliminary report of 6 years of experience

    Pasquale Rosito;Antonia F. Mancini;Roberto Rondelli;Massimo E. Abate

  • Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol

    G Bacci;A Briccoli;S Ferrari;A Longhi

  • Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution

    Emanuela Palmerini;Eric L. Staals;Marco Alberghini;Licciana Zanella

Frequent Co-Authors

Piero Picci
Piero Picci University of Bologna
Franco Bertoni
Franco Bertoni Ospedale San Donato
Stefano Ferrari
Stefano Ferrari Veneto Eye Bank Foundation
Franca Fagioli
Franca Fagioli University of Turin
Katia Scotlandi
Katia Scotlandi Wayne State University
Paolo G. Casali
Paolo G. Casali University of Milan
Nicola Baldini
Nicola Baldini University of Bologna
Milena Fini
Milena Fini University of Bologna
Roberto Giardino
Roberto Giardino University of Bologna
Alessandro Gronchi
Alessandro Gronchi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a physician—there are numerous online degrees that open doors to in-demand medical careers. For those already in nursing, dnp online programs cheap can be an affordable way to achieve the highest level of clinical nursing education and leadership roles.

If you are interested in pharmacy, you can explore online pharmacist degree options that provide flexibility while preparing you for licensure and advanced practice.

Technology-focused students might consider an online bachelor's in health information management. This growing field combines healthcare with data systems, offering strong job prospects in hospitals, insurance companies, and beyond.

Additionally, starting a healthcare career is possible with medical billing and coding online programs. These short, affordable courses can quickly lead to certification and remote job opportunities.

Exploring these related online options makes it possible to find a healthcare pathway that matches your interests, schedule, and budget.

Best Scientists Citing Mario Mercuri

Recently Published Articles